📰 Merck Sharp News
Page 40 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
April 17, 2023
Adding pembrolizumab to frontline chemotherapy improves overall survival in patients with advanced biliary tract cancer, a phase 3 trial suggests.
April 16, 2023
Pembrolizumab plus cisplatin and gemcitabine produced a statistically significant and clinically meaningful improvement in overall survival vs placebo plus cisplatin and gemcitabine in previously untreated patients with advanced biliary tract cancer, according to data from the phase 3 KEYNOTE-966 trial.
April 11, 2023
Pembrolizumab plus ICE chemotherapy appears effective as second-line treatment in patients with transplant-eligible Hodgkin lymphoma.
April 7, 2023
A federal judge in DC has reminded us that the government does not operate in secret, at least not always and usually not completely in connection…
April 6, 2023
A novel chimeric antigen receptor T-cell therapy induced clinically impactful antitumor responses in 63% of younger patients with relapsed or refractory, high-risk neuroblastoma, results of a phase 1/phase 2 trial showed.The findings, published in The New England Journal of Medicine, suggest the investigational agent also has a manageable safety profile similar to other CAR T-cell therapies,
April 6, 2023
Where a plaintiff claiming that he suffered injuries after prolonged ingestion of a prescription drug has filed a complaint alleging an inadequate warning label, the complaint should not be dismissed, as the defendants’ contacts with Massachusetts were sufficient to warrant the exercise of personal jurisdiction. “Richard McLaughlin (‘McLaughlin’ or ‘Plaintiff’) has brought this action against
April 5, 2023
Pembrolizumab plus ICE chemotherapy appears effective as second-line treatment in patients with transplant-eligible Hodgkin lymphoma.
April 4, 2023
/PRNewswire/ -- Flamingo Therapeutics ("Flamingo") today announced the appointment of Andrew E. Denker, MD, PhD., as Chief Medical Officer. Dr. Denker is a...
April 3, 2023
Many CEOs of multinational companies have confirmed their attendance at the 6th China International Import Expo, the organizer announced during a promotional event for the annual expo's medical equipment and healthcare products zone on March 31.
April 3, 2023
03.04.2023 - Expect to complete patient enrollment in the randomized Phase 1/2a SIGNAL-AD Alzheimer’s study in April 2023 with topline data anticipated mid-2024 Completed enrollment of 36 patients required for a pre-planned interim analysis of KEYNOTE B84 ...